|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5877193A
(en)
|
1996-07-19 |
1999-03-02 |
Hoffmann-La Roche Inc. |
Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
|
|
AU741482B2
(en)
|
1997-05-07 |
2001-11-29 |
Allergan Pharmaceuticals International Limited |
Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
|
|
CA2349832A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
|
ATE250932T1
(de)
|
1999-07-16 |
2003-10-15 |
Warner Lambert Co |
Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer
|
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
FR2836917B1
(fr)
|
2002-03-11 |
2006-02-24 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif
|
|
CA2744893A1
(en)
|
2002-06-27 |
2004-01-08 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as glucokinase activators
|
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
CA2531418A1
(en)
|
2003-07-08 |
2005-01-20 |
Novartis Ag |
Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
|
|
CN1863785A
(zh)
*
|
2003-08-08 |
2006-11-15 |
沃泰克斯药物股份有限公司 |
在疼痛的治疗中用作钠或钙通道阻断剂的杂芳基氨基磺酰基苯基衍生物
|
|
KR20060073930A
(ko)
|
2003-08-08 |
2006-06-29 |
버텍스 파마슈티칼스 인코포레이티드 |
통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
|
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
WO2006066109A2
(en)
|
2004-12-17 |
2006-06-22 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
WO2007039171A1
(en)
|
2005-10-06 |
2007-04-12 |
Sanofi-Aventis |
4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
|
|
WO2007075895A2
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
KR101117931B1
(ko)
|
2006-08-15 |
2012-04-12 |
에프. 호프만-라 로슈 아게 |
페닐, 피리딘 및 퀴놀린 유도체
|
|
RU2474582C2
(ru)
|
2006-10-19 |
2013-02-10 |
СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Гетероарильные соединения, их композиции и их применение в качестве ингибиторов протеинкиназы
|
|
US8853250B2
(en)
|
2007-07-13 |
2014-10-07 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
JP5460589B2
(ja)
*
|
2007-07-13 |
2014-04-02 |
アイカジェン， インコーポレイテッド |
ナトリウムチャネル阻害物質
|
|
WO2009013171A2
(en)
|
2007-07-24 |
2009-01-29 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
CA2701946A1
(en)
*
|
2007-10-11 |
2009-04-16 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
|
NZ588983A
(en)
|
2008-06-25 |
2011-11-25 |
Daiichi Sankyo Co Ltd |
Carboxylic acid compound
|
|
EP2307412A2
(en)
|
2008-07-01 |
2011-04-13 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
GB0815947D0
(en)
*
|
2008-09-02 |
2008-10-08 |
Univ Dundee |
Compounds
|
|
US20110294853A1
(en)
|
2008-09-12 |
2011-12-01 |
Benjamin Pelcman |
Bis Aromatic Compounds for Use in the Treatment of Inflammation
|
|
CA2747419C
(en)
|
2009-01-12 |
2014-07-08 |
Icagen, Inc. |
Sulfonamide derivatives
|
|
WO2012004743A1
(en)
|
2010-07-09 |
2012-01-12 |
Pfizer Limited |
Benzenesulfonamides useful as sodium channel inhibitors
|
|
BR112013003864B1
(pt)
|
2010-08-20 |
2021-08-31 |
Hutchison Medipharma Limited |
Compostos de pirrolpirimidina, composição e uso dos mesmos
|
|
AU2012296529A1
(en)
|
2011-08-17 |
2014-02-20 |
Amgen Inc. |
Heteroaryl sodium channel inhibitors
|
|
AU2012328561A1
(en)
|
2011-10-28 |
2014-04-17 |
Merck Sharp & Dohme Corp. |
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
|
|
MX2014005304A
(es)
|
2011-10-31 |
2015-03-20 |
Xenon Pharmaceuticals Inc |
Biaril eter sulfonamidas y su uso como agentes terapeuticos.
|
|
ES2586213T3
(es)
*
|
2011-10-31 |
2016-10-13 |
Xenon Pharmaceuticals Inc. |
Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
WO2013122897A1
(en)
|
2012-02-13 |
2013-08-22 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
CA2874621A1
(en)
*
|
2012-05-22 |
2013-11-28 |
Genentech, Inc. |
N-substituted benzamides and their use in the treatment of pain
|
|
US9376429B2
(en)
|
2012-10-15 |
2016-06-28 |
Daewoong Pharmaceutical Co., Ltd. |
Sodium channel blockers, preparation method thereof and use thereof
|
|
JP2015535251A
(ja)
|
2012-10-26 |
2015-12-10 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
電位作動型ナトリウムチャネルにおいて選択的活性を有するベンゾオキサゾリノン化合物
|
|
AU2013334664A1
(en)
|
2012-10-26 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
TW201512171A
(zh)
|
2013-04-19 |
2015-04-01 |
Pfizer Ltd |
化學化合物
|
|
TW201443025A
(zh)
|
2013-04-19 |
2014-11-16 |
Pfizer Ltd |
化學化合物
|
|
US9212182B2
(en)
|
2013-06-12 |
2015-12-15 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
GB201310542D0
(en)
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
WO2015035278A1
(en)
|
2013-09-09 |
2015-03-12 |
Bristol-Myers Squibb Company |
RORγ MODULATORS
|
|
CN105611923B
(zh)
|
2013-09-10 |
2019-08-23 |
卓莫赛尔公司 |
用于治疗疼痛和糖尿病的钠通道调节剂
|
|
WO2015077905A1
(en)
|
2013-11-29 |
2015-06-04 |
Merck Sharp & Dohme Corp. |
Bicycloamine-substituted-n-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
CA2934473C
(en)
|
2013-12-23 |
2019-08-20 |
Purdue Pharma L.P. |
Indazoles and use thereof
|
|
AU2015223049B2
(en)
*
|
2014-02-27 |
2019-03-21 |
Merck Patent Gmbh |
Heterocyclic compounds as NaV channel inhibitors and uses thereof
|
|
TW202140422A
(zh)
*
|
2014-10-06 |
2021-11-01 |
美商維泰克斯製藥公司 |
囊腫纖維化症跨膜傳導調節蛋白之調節劑
|
|
KR102412146B1
(ko)
*
|
2015-02-11 |
2022-06-22 |
주식회사 아이엔테라퓨틱스 |
소디움 채널 차단제
|
|
CN106795149B
(zh)
|
2015-05-05 |
2019-09-24 |
上海海雁医药科技有限公司 |
双环取代的苯磺酰胺衍生物、其制法与医药上的用途
|
|
BR112018012408A2
(pt)
|
2015-12-18 |
2018-12-04 |
Merck Sharp & Dohme |
?composto, composição, e, método para tratar um distúrbio de dor ou distúrbio de tosse ou de coceira aguda ou de coceira crônica?
|
|
WO2017201468A1
(en)
|
2016-05-20 |
2017-11-23 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
US10668067B2
(en)
*
|
2016-07-20 |
2020-06-02 |
Amgen Inc. |
Pyridine sulfonamides
|
|
TW201811766A
(zh)
*
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|
|
US10968210B2
(en)
|
2016-11-17 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
EP3551626B1
(en)
|
2016-12-09 |
2023-10-25 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
BR112021001135A2
(pt)
*
|
2018-07-27 |
2021-04-20 |
Xenon Pharmaceuticals Inc. |
compostos e composições farmacêuticas para tratar epilepsia ou transtorno convulsivo epiléptico
|